E-book PDF (10,45 Mb)
Compatible solo con Adobe Acrobat Reader - software gratuito - (descubra cómo abrir los archivos)

Glycogen Synthase Kinase 3 (GSK-3) and Its Inhibitors : Drug Discovery and Development

2006 - John Wiley et Sons Ltd.

384 p.

Many researchers believe that GSK-3 and its inhibitors could lead to effective treatments for neurogenerative disorders, type II diabetes, depression and bipolar disorder, and some forms of cancer. This book provides a thorough introduction to GSK-3, presents up-to-date information, and mentions the birth of several chemical families of GSK-3 inhibitors with varying selectivity. It's a great reference for researchers in drug design and development. [Publisher's Text]

100000 characters.